Richard C. Brundage
- Virology top 0.5%
- HIV Research and Treatment 27
- Transplantation top 1%
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 31
- HIV/AIDS Research and Interventions 13
-
- Pharmacological Effects and Toxicity Studies 35
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 14
- Pharmacogenetics and Drug Metabolism 12
-
- Epilepsy research and treatment 27
-
- Drug Transport and Resistance Mechanisms 21
- Co-authors
- Courtney V. FletcherAngela K. BirnbaumPeter L. AndersonThomas N. KakudaEdward P. AcostaHenry H. BalfourPamala A. JacobsonRory P. Remmel
- Journals
- The Journal of Clinical Pharmacology (15 papers)Clinical Pharmacology & Therapeutics (8 papers)British Journal of Clinical Pharmacology (8 papers)
- Partner nations
- United StatesSwitzerlandEgypt
In The Last Decade
Richard C. Brundage
133 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 121
- Virology 814
- Transplantation 336
- Infectious Diseases 1.5k
- Pediatrics, Perinatology and Child Health 1.1k
- Pharmacology 315
Countries citing papers authored by Richard C. Brundage
This map shows the geographic impact of Richard C. Brundage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Brundage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Brundage more than expected).
Fields of papers citing papers by Richard C. Brundage
This network shows the impact of papers produced by Richard C. Brundage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Brundage. The network helps show where Richard C. Brundage may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard C. Brundage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 3 | |
| 4 | 2020 | 13 | |
| 5 | 2019 | 6 | |
| 6 | 2019 | 15 | |
| 7 | 2017 | 10 | |
| 8 | 2015 | 59 | |
| 9 | 2013 | 23 | |
| 10 | 2011 | 17 | |
| 11 | 2011 | 21 | |
| 12 | 2008 | 30 | |
| 13 | 2007 | 27 | |
| 14 | 2006 | 15 | |
| 15 | 2006 | 35 | |
| 16 | 2005 | 33 | |
| 17 | 2002 | 26 | |
| 18 | 1998 | 37 | |
| 19 | 1988 | 58 | |
| 20 | 1986 | 1 |
About Richard C. Brundage
Richard C. Brundage is a scholar working on Virology, Transplantation and Pediatrics, Perinatology and Child Health, having authored 136 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (35 papers), HIV/AIDS drug development and treatment (31 papers), HIV Research and Treatment (27 papers), Epilepsy research and treatment (27 papers), Drug Transport and Resistance Mechanisms (21 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), HIV/AIDS Research and Interventions (13 papers) and Pharmacogenetics and Drug Metabolism (12 papers). The work is most often cited by research in Virology (814 citations), Transplantation (336 citations) and Infectious Diseases (1.5k citations). Richard C. Brundage has collaborated with scholars based in United States, Switzerland and Egypt. Frequent co-authors include Courtney V. Fletcher, Angela K. Birnbaum, Peter L. Anderson, Thomas N. Kakuda, Edward P. Acosta, Henry H. Balfour, Pamala A. Jacobson, Rory P. Remmel, Ilo E. Leppik and James C. Cloyd. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Epilepsia and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.